PCH
ALNY icon

PGIM Custom Harvest’s Alnylam Pharmaceuticals ALNY Stock Holding History

PGIM Custom Harvest’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$246K Buy
1,304
+10
+0.8% +$1.88K 0.04% 174
2021
Q2 		$219K Buy
+1,294
New +$190K 0.04% 164

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PGIM Custom Harvest's ALNY Position: Q3 2021 in Review

PGIM Custom Harvest increased its Alnylam Pharmaceuticals (ALNY) stake by 0.77% in Q3 2021, buying an estimated $1.88K and bringing the position to 1,304 shares worth $246K. The position accounts for 0.04% of the portfolio, ranked #174.

PGIM Custom Harvest first reported a position in ALNY in Q2 2021 and has held it in 2 quarters since. 405 funds tracked by Wall St. Rank hold ALNY as of Q3 2021.

  • PGIM Custom Harvest held 1,304 shares of Alnylam Pharmaceuticals worth $246K as of Q3 2021.
  • PGIM Custom Harvest bought 10 Alnylam Pharmaceuticals shares in Q3 2021, an estimated $1.88K.
  • Alnylam Pharmaceuticals made up 0.04% of PGIM Custom Harvest's portfolio in Q3 2021, its #174 holding.
  • PGIM Custom Harvest first reported a position in Alnylam Pharmaceuticals in Q2 2021 and has held it in 2 quarters since.
  • 405 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2021.

Based on PGIM Custom Harvest's 13F filing for Q3 2021, filed 12 Nov 2021.